DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,366,817 | +1.5% | 61,938 | -1.8% | 0.67% | +7.6% |
| Q2 2023 | $15,136,080 | -7.0% | 63,067 | -2.4% | 0.62% | -10.5% |
| Q1 2023 | $16,281,279 | -7.0% | 64,598 | -2.1% | 0.70% | -11.8% |
| Q4 2022 | $17,508,164 | -0.8% | 65,964 | -3.5% | 0.79% | -6.9% |
| Q3 2022 | $17,650,000 | -0.2% | 68,333 | -2.0% | 0.85% | +8.2% |
| Q2 2022 | $17,677,000 | -14.8% | 69,727 | -1.5% | 0.78% | -4.8% |
| Q1 2022 | $20,759,000 | -9.0% | 70,770 | +2.1% | 0.82% | -4.9% |
| Q4 2021 | $22,813,000 | -5.8% | 69,337 | -12.9% | 0.86% | -15.8% |
| Q3 2021 | $24,226,000 | +13.5% | 79,577 | +0.1% | 1.02% | +18.2% |
| Q2 2021 | $21,337,000 | +19.1% | 79,510 | -0.1% | 0.87% | +14.5% |
| Q1 2021 | $17,912,000 | +1.9% | 79,581 | +0.5% | 0.76% | -3.7% |
| Q4 2020 | $17,584,000 | +2.6% | 79,157 | -0.6% | 0.79% | -5.3% |
| Q3 2020 | $17,144,000 | +20.9% | 79,616 | -0.7% | 0.83% | +6.0% |
| Q2 2020 | $14,181,000 | +27.1% | 80,196 | -0.5% | 0.78% | +11.9% |
| Q1 2020 | $11,153,000 | -9.1% | 80,580 | +0.8% | 0.70% | +14.0% |
| Q4 2019 | $12,275,000 | +9.3% | 79,978 | +2.9% | 0.61% | +2.8% |
| Q3 2019 | $11,227,000 | +3.0% | 77,732 | +1.9% | 0.60% | -1.5% |
| Q2 2019 | $10,905,000 | +11.2% | 76,301 | +2.8% | 0.61% | +6.5% |
| Q1 2019 | $9,803,000 | +25.2% | 74,254 | -2.2% | 0.57% | +7.2% |
| Q4 2018 | $7,829,000 | -1.8% | 75,917 | +3.4% | 0.53% | +9.3% |
| Q3 2018 | $7,976,000 | +13.9% | 73,404 | +3.5% | 0.49% | +14.6% |
| Q2 2018 | $7,000,000 | -1.0% | 70,936 | -1.8% | 0.42% | -5.8% |
| Q1 2018 | $7,074,000 | +5.9% | 72,245 | +0.4% | 0.45% | +6.1% |
| Q4 2017 | $6,679,000 | +5.7% | 71,953 | -2.3% | 0.42% | +0.7% |
| Q3 2017 | $6,316,000 | -0.8% | 73,626 | -2.4% | 0.42% | -7.9% |
| Q2 2017 | $6,368,000 | +0.9% | 75,457 | +2.3% | 0.46% | -1.1% |
| Q1 2017 | $6,311,000 | +15.9% | 73,791 | +5.5% | 0.46% | +6.0% |
| Q4 2016 | $5,447,000 | +5.0% | 69,976 | -0.3% | 0.44% | -21.3% |
| Q3 2016 | $5,188,000 | -20.6% | 70,205 | +8.5% | 0.55% | -24.0% |
| Q2 2016 | $6,538,000 | +6.8% | 64,733 | +0.3% | 0.73% | +1.4% |
| Q1 2016 | $6,121,000 | -1.0% | 64,526 | -3.1% | 0.72% | -2.6% |
| Q4 2015 | $6,183,000 | +11.2% | 66,575 | +2.0% | 0.74% | -1.6% |
| Q3 2015 | $5,562,000 | +11.5% | 65,280 | +11.9% | 0.75% | +15.2% |
| Q2 2015 | $4,990,000 | +9.4% | 58,312 | +8.6% | 0.65% | +4.8% |
| Q1 2015 | $4,560,000 | +24.0% | 53,704 | +25.2% | 0.62% | +14.8% |
| Q4 2014 | $3,676,000 | +27.1% | 42,882 | +12.6% | 0.54% | +16.8% |
| Q3 2014 | $2,893,000 | +7.3% | 38,070 | +11.1% | 0.46% | +1.8% |
| Q2 2014 | $2,697,000 | +6.3% | 34,261 | +1.3% | 0.46% | -4.2% |
| Q1 2014 | $2,537,000 | +16.3% | 33,820 | +19.7% | 0.48% | +5.3% |
| Q4 2013 | $2,182,000 | +39.2% | 28,264 | +25.0% | 0.45% | +16.2% |
| Q3 2013 | $1,567,000 | +137.4% | 22,610 | +116.9% | 0.39% | +95.0% |
| Q2 2013 | $660,000 | – | 10,423 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |